Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
This grant funds exploratory and developmental research in bioengineering.
About this program
The Exploratory/Developmental Bioengineering Research Grants (EBRG) program supports innovative research projects that aim to advance the field of bioengineering. This grant is designed for researchers who are looking to explore new ideas and develop novel technologies that can improve healthcare outcomes. It is particularly aimed at early-stage investigators and those who are venturing into new areas of bioengineering research. The program encourages the development of new methodologies and approaches that can lead to significant advancements in the field. Eligible applicants include academic institutions, nonprofit organizations, and other research entities that are engaged in bioengineering research. The grant allows for clinical trials, providing flexibility for researchers to test their innovative ideas in real-world settings. The funding can be used for a variety of research activities, including preliminary studies, technology development, and pilot projects that have the potential to lead to larger-scale investigations.
Eligibility
Academic institutions, nonprofit organizations, and research entities engaged in bioengineering research.